Literature DB >> 18263757

Spinal muscular atrophy with respiratory distress type 1 (SMARD1).

Angela M Kaindl1, Ulf-Peter Guenther, Sabine Rudnik-Schöneborn, Raymonda Varon, Klaus Zerres, Markus Schuelke, Christoph Hübner, Katja von Au.   

Abstract

Autosomal recessive spinal muscular atrophy with respiratory distress type 1 (SMARD1), recently referred to as distal spinal muscular atrophy 1 (DSMA1; MIM#604320) and also known as distal hereditary motor neuropathy type 6 (dHMN6 or HMN6), results from mutations in the IGHMBP2 gene on chromosome 11q13.3 encoding the immunoglobulin micro-binding protein 2. In contrast to the infantile spinal muscular atrophy type 1 (SMA1; Werdnig-Hoffmann disease) with weakness predominantly of proximal muscles and bell-shaped thorax deformities due to intercostal muscle atrophy, infants with distal spinal muscular atrophy 1 usually present with distal muscle weakness, foot deformities, and sudden respiratory failure due to diaphragmatic paralysis that often requires urgent intubation. In this article, the authors review the clinical, neuropathological, and genetic aspects of distal spinal muscular atrophy 1 and discuss differential diagnoses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18263757     DOI: 10.1177/0883073807310989

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  11 in total

1.  Infantile-onset spinal muscular atrophy with respiratory distress-1 diagnosed in a 20-year-old man.

Authors:  Tyler Mark Pierson; Gary Tart; David Adams; Camilo Toro; Gretchen Golas; Cynthia Tifft; William Gahl
Journal:  Neuromuscul Disord       Date:  2011-02-25       Impact factor: 4.296

2.  Rescue of a Mouse Model of Spinal Muscular Atrophy With Respiratory Distress Type 1 by AAV9-IGHMBP2 Is Dose Dependent.

Authors:  Monir Shababi; Zhihua Feng; Eric Villalon; Christine M Sibigtroth; Erkan Y Osman; Madeline R Miller; Patricka A Williams-Simon; Abby Lombardi; Thalia H Sass; Arleigh K Atkinson; Michael L Garcia; Chien-Ping Ko; Christian L Lorson
Journal:  Mol Ther       Date:  2016-02-10       Impact factor: 11.454

3.  Perinatal inflammation results in decreased oligodendrocyte numbers in adulthood.

Authors:  Amanda E Graf; Krista M Haines; Christopher R Pierson; Brad N Bolon; Ronald H Houston; Markus Velten; Kathryn M Heyob; Lynette K Rogers
Journal:  Life Sci       Date:  2013-11-28       Impact factor: 5.037

4.  Truncating and missense mutations in IGHMBP2 cause Charcot-Marie Tooth disease type 2.

Authors:  Ellen Cottenie; Andrzej Kochanski; Albena Jordanova; Boglarka Bansagi; Magdalena Zimon; Alejandro Horga; Zane Jaunmuktane; Paola Saveri; Vedrana Milic Rasic; Jonathan Baets; Marina Bartsakoulia; Rafal Ploski; Pawel Teterycz; Milos Nikolic; Ros Quinlivan; Matilde Laura; Mary G Sweeney; Franco Taroni; Michael P Lunn; Isabella Moroni; Michael Gonzalez; Michael G Hanna; Conceicao Bettencourt; Elodie Chabrol; Andre Franke; Katja von Au; Markus Schilhabel; Dagmara Kabzińska; Irena Hausmanowa-Petrusewicz; Sebastian Brandner; Siew Choo Lim; Haiwei Song; Byung-Ok Choi; Rita Horvath; Ki-Wha Chung; Stephan Zuchner; Davide Pareyson; Matthew Harms; Mary M Reilly; Henry Houlden
Journal:  Am J Hum Genet       Date:  2014-10-30       Impact factor: 11.025

5.  The Ighmbp2D564N mouse model is the first SMARD1 model to demonstrate respiratory defects.

Authors:  Caley E Smith; Monique A Lorson; Sara M Ricardez Hernandez; Zayd Al Rawi; Jiude Mao; Jose Marquez; Eric Villalón; Amy N Keilholz; Catherine L Smith; Mona O Garro-Kacher; Toni Morcos; Daniel J Davis; Elizabeth C Bryda; Nicole L Nichols; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2022-04-22       Impact factor: 5.121

Review 6.  Clinical and molecular features and therapeutic perspectives of spinal muscular atrophy with respiratory distress type 1.

Authors:  Fiammetta Vanoli; Paola Rinchetti; Francesca Porro; Valeria Parente; Stefania Corti
Journal:  J Cell Mol Med       Date:  2015-06-20       Impact factor: 5.310

Review 7.  Spinal muscular atrophy with respiratory distress type 1: Clinical phenotypes, molecular pathogenesis and therapeutic insights.

Authors:  Matteo Saladini; Monica Nizzardo; Alessandra Govoni; Michela Taiana; Nereo Bresolin; Giacomo P Comi; Stefania Corti
Journal:  J Cell Mol Med       Date:  2019-12-04       Impact factor: 5.310

8.  The Ighmbp2 helicase structure reveals the molecular basis for disease-causing mutations in DMSA1.

Authors:  Siew Choo Lim; Matthew W Bowler; Ting Feng Lai; Haiwei Song
Journal:  Nucleic Acids Res       Date:  2012-09-10       Impact factor: 16.971

9.  Spinal muscular atrophy with respiratory distress type 1 (SMARD1) Report of a Spanish case with extended clinicopathological follow-up.

Authors:  Beatriz San Millan; Jose M Fernandez; Carmen Navarro; Alfredo Reparaz; Susana Teijeira
Journal:  Clin Neuropathol       Date:  2016 Mar-Apr       Impact factor: 1.368

10.  Spinal Muscular Atrophy With Respiratory Distress Type 1-A Child With Atypical Presentation.

Authors:  Annie Ting Gee Chiu; Sophelia Hoi Shan Chan; Shun Ping Wu; Shun Hin Ting; Brian Hon Yin Chung; Angel On Kei Chan; Virginia Chun Nei Wong
Journal:  Child Neurol Open       Date:  2018-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.